Delivery Order 47QTCB22D0090-75F40122F80425
- This is a $1,960,158.65 delivery order awarded by the Food and Drug Administration (FDA) to Agilistek LLC, an 8(a) certified small disadvantaged business, for the FDA Foreign Inspection Planning and Scheduling System (FIPSS) Phase 4 project. The purpose of this modification is to de-obligate funds and close out the contract. Agilistek, a minority-owned IT services firm, has secured multiple contracts with the FDA to develop, enhance, and maintain the FIPSS system, which supports critical...
- The Food and Drug Administration issued a $4.49 million delivery order to Agilistek LLC on August 7, 2024, under the 8(a) STARS III GWAC for the Foreign Inspection Planning and Scheduling System (FIPSS), awarded as an 8(a) sole source set-aside. Agilistek is a minority-owned small disadvantaged business certified as a Subcontinent Asian American-owned firm. The 8(a) STARS III GWAC is a General Services Administration–administered governmentwide acquisition contract for IT services and...
- This is a $30,676.16 firm fixed-price purchase order awarded by the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC), a civilian agency, to Agilistek LLC, a minority-owned small disadvantaged business. The contract is for the payment of a protest claim and associated attorneys' fees and expenses related to the CIO-SP4 solicitation. Agilistek is a key contractor for the Food and Drug Administration (FDA), providing IT services and solutions,...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) has awarded a firm fixed-price delivery order contract to Estars Enterprise, LLC, a minority-owned small business, to provide operations and maintenance support for the FDA's Foreign Inspection Program Package System (FIPPS). The contract, valued at $3,688,969.08, was awarded under the 8(a) Streamlined Technology Acquisition Resources for Services (8(a) STARS II) government-wide acquisition contract and has an...
- The Department of Health and Human Services Food and Drug Administration (FDA) has awarded a $3,881,213.30 delivery order to AC Integrity Partners LLC, a Small Disadvantaged Business and Women-Owned Small Business, to provide a full range of IT lifecycle activities in support of the FDA's IT modernization efforts related to the agency's engagement with its regulatory partners. The work will be performed in Herndon, Virginia over a one-year base period under the 8(a) STARS III Government-wide...
- This is a federal contract award from the U.S. Food and Drug Administration (FDA) to Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract is for $2,538,816.41 and provides office support services to the FDA's Office of Clinical Policy. The contract is a Delivery Order issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and...
- This is a delivery order under the Department of Health and Human Services Food and Drug Administration's 8(a) Streamlined Technology Acquisition Resources for Services (8(a) STARS II) government-wide acquisition contract. The award, valued at $4,138,693.31, was made to Estars Enterprise, LLC, a minority-owned small business, to provide a Foreign Inspection Planning and Scheduling System (FIPSS). Estars Enterprise, LLC is a wholly owned subsidiary of ADG TECH Consulting LLC, another...
- This is a $3,521,299.46 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to AC Integrity Partners LLC, a small disadvantaged business joint venture. The contract is for information technology management, business solutions, and automation support services to modernize the IT capabilities of the FDA's Office of Regulatory Affairs. The work will be performed in Herndon, Virginia over a period ending September 2024. This contract was awarded under the...
- The Department of Health and Human Services Food and Drug Administration awarded a $4.4 million delivery order contract to Estars Enterprise, LLC under the 8a STARS II government-wide acquisition contract vehicle. Estars Enterprise will provide Phase 2 DME work in support of the FDA's FIPPS program through May 2022. As the prime contractor, Estars Enterprise will leverage its parent company, ADG TECH Consulting, to complete the contract objectives. The contract is funded by the FDA and...
- The Food and Drug Administration awarded a delivery order valued at $1.73M to Arlluk Technology Solutions LLC for CAAS Operations and Maintenance Infrastructure Support Services, with an ultimate completion date of September 24, 2025. This contract was issued under a firm fixed-price arrangement with no set-aside designation and represents support for FDA's cost efficiency initiative. Arlluk Technology Solutions LLC is an SBA-certified 8(a) small disadvantaged business and subsidiary of...
- 8(a) STARS III (STARS III)Master GWAC
- 47QTCB22D0090Government Wide Acquisition Contract (GWAC)
- 47QTCB22D0090-75F40122F80425Delivery Order
Agilistek LLC has received two delivery orders totaling $5,545,437.75 from the Department of Health and Human Services' Food and Drug Administration (FDA) to provide information technology services supporting the agency's Foreign Inspection Planning and Scheduling System (FIPSS). The orders were issued through the 8(a) Streamlined Technology Acquisition Resources for Services III (STARS III) Governmentwide Acquisition Contract (GWAC), an indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle with a $50 billion ceiling available for IT solutions. The first delivery order, valued at $2,755,437.75, is for Phase 3 services enhancing FIPSS between September 2023 and September 2024. A second order, valued at $2,789,000, continued Phase 4 support through the following year. Both were set aside for small disadvantaged businesses certified under Section 8(a) of the Small Business Act and utilize labor hour pricing. Agilistek, a minority-owned 8(a) firm, will provide ongoing development and maintenance of the FDA's foreign inspection planning and scheduling system from its Derwood, Maryland location.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||